Evidence map›Paper›PMID 36621243›Full record

ArticleEnfermedades infecciosas y microbiologia clinica (English ed.)2023

Lifting COVID-19 mitigation measures in Spain (May-June 2020).

Susana Monge, Pello Latasa Zamalloa, María José Sierra Moros, Oscar Pérez Olaso, Lucía García San Miguel, Carmen Varela, Silvia Rivera Ariza, María C Vázquez Torres, María Del Carmen Olmedo Lucerón, Paloma González Yuste and 37 more

Abstract read
In one paragraph

Article in Enfermedades infecciosas y microbiologia clinica (English ed.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

47 authors.

Susana MongeMinistry of Health, Madrid, Spain. Electronic address: smonge@mscbs.es.
Pello Latasa ZamalloaMinistry of Health, Madrid, Spain.
María José Sierra MorosMinistry of Health, Madrid, Spain.
Oscar Pérez OlasoMinistry of Health, Madrid, Spain.
Lucía García San MiguelMinistry of Health, Madrid, Spain.
Carmen VarelaNational Centre of Epidemiology, Instituto de Salud Carlos III, CIBER Epidemiología y Salud Pública, Madrid, Spain.
Silvia Rivera ArizaMinistry of Health, Madrid, Spain.
María C Vázquez TorresMinistry of Health, Madrid, Spain.
María Del Carmen Olmedo LucerónMinistry of Health, Madrid, Spain.
Paloma González YusteMinistry of Health, Madrid, Spain.
Pilar Soler CrespoMinistry of Health, Madrid, Spain.
Javier Segura Del PozoMadrid Salud (Madrid Council Public Health Agency), Madrid, Spain.
Pedro GullónAPLICA Investigación y Traslación Soc Coop Mad, Madrid, Spain.
José Miguel CarrascoAPLICA Investigación y Traslación Soc Coop Mad, Madrid, Spain.
Elena Vanessa Martínez SánchezMinistry of Health, Madrid, Spain.
Lidia Redondo BravoMinistry of Health, Madrid, Spain.
Myriam Pichiule CastañedaMinistry of Health, Madrid, Spain.
María Jesús Purriños HermidaGeneral Directorate of Public Health, Autonomous Community of Galicia, Spain.
Xurxo Hervada VidalGeneral Directorate of Public Health, Autonomous Community of Galicia, Spain.
Ismael Huerta GonzalezGeneral Directorate of Public Health, Principality of Asturias, Spain.
Mario MargollesGeneral Directorate of Public Health, Principality of Asturias, Spain.
Hermelinda Vanaclocha LunaSubdirectorate of Epidemiology and Public Health Surveillance, Autonomous Community of Valencia, Spain.
Enrique Ramalle GómaraGeneral Directorate of Public Health, Consumption and Care, Autonomous Community of La Rioja, Spain.
Jaime Jesús Pérez MartínGeneral Directorate of Public Health and Addictions, IMIB-Arrixaca. Murcia University, Region of Murcia, Spain.
María Dolores Chirlaque LópezGeneral Directorate of Public Health and Addictions, IMIB-Arrixaca. Murcia University, Region of Murcia, Spain.
María Jesús López FernándezExtremadura Health Service, Autonomous Community of Extremadura, Spain.
Nicola LorussoGeneral Directorate of Public Health and Pharmacy, Autonomous Community of Andalusia, Spain.
Alberto Carmona UbagoGeneral Directorate of Public Health and Pharmacy, Autonomous Community of Andalusia, Spain.
Ana Rivas PerezMinistry of Health, Autonomous City of Ceuta, Spain.
Violeta Ramos MarinMinistry of Health, Autonomous City of Ceuta, Spain.
Juan José Criado AlvarezHealth Sciences Institute of Castile-La Mancha, Autonomous Community of Castile-La Mancha, Spain.
Daniel Castrillejo PérezGeneral Directorate of Public Health and Consumption, Autonomous City of Melilla, Spain.
Atanasio A Góméz AnésGeneral Directorate of Public Health and Consumption, Autonomous City of Melilla, Spain.
Marga FronteraMinistry of Health, Balearic Islands, Spain.
Pedro Macias RodriguezMinistry of Health, Balearic Islands, Spain.
Eva Elisa Álvarez LeónGeneral Directorate of Public Health, Canary Islands, Spain.
Miriam Díaz CasañasGeneral Directorate of Public Health, Canary Islands, Spain.
Maria Angeles Lopaz PerezGeneral Directorate of Public Health, Autonomous Community of Madrid, Spain.
Juan Pablo Alonso Pérez de ÁgredaGeneral Directorate of Public Health, Autonomous Community of Aragón, Spain.
Paloma Navas GutierrezGeneral Directorate of Public Health, Autonomous Community of Cantabria, Spain.
Ignacio Rosell AguilarGeneral Directorate of Public Health, Autonomous Community of Castilla y León, Spain.
Jose María Arteagoitia AxpeGeneral Directorate of Public Health and Addictions, Basque Country, Spain.
Fernando Gonzalez CarrilGeneral Directorate of Public Health and Addictions, Basque Country, Spain.
Pilar Aparicio AzcárragaMinistry of Health, Madrid, Spain.
Fernando Simón SoriaMinistry of Health, Madrid, Spain.
Berta Suarez RodríguezMinistry of Health, Madrid, Spain.
Members of the Technical advisory group for the lifting of lockdown measures

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe state of alarm was declared in Spain due to the COVID-19 epidemic on March 14, 2020, and established population confinement measures. The objective is to describe the process of lifting these mitigation measures.

methodsThe Plan for the Transition to a New Normality, approved on April 28, contained four sequential phases with progressive increase in socio-economic activities and population mobility. In parallel, a new strategy for early diagnosis, surveillance and control was implemented. A bilateral decision mechanism was established between the Spanish Government and the autonomous communities (AC), guided by a set of qualitative and quantitative indicators capturing the epidemiological situation and core capacities. The territorial units were established ad-hoc and could be from Basic Health Zones to entire AC.

resultsThe process run from May 4 to June 21, 2020. AC implemented plans for reinforcement of core capacities. Incidence decreased from a median (50% of territories) of 7.4 per 100,000 in 7 days at the beginning to 2.5 at the end. Median PCR testing increased from 53% to 89% of suspected cases and PCR total capacity from 4.5 to 9.8 per 1000 inhabitants weekly; positivity rate decreased from 3.5% to 1.8%. Median proportion of cases with traced contacts increased from 82% to 100%.

conclusionSystematic data collection, analysis, and interterritorial dialogue allowed adequate process control. The epidemiological situation improved but, mostly, the process entailed a great reinforcement of core response capacities nation-wide, under common criteria. Maintaining and further reinforcing capacities remained crucial for responding to future waves.

Indexed as

COVID-19COVID-19 TestingHumansSARS-CoV-2SpainCapacidadesConfinamientoConfinementCoronavirusCOVID-19DeconfinementDesescaladaHealth sector capacityMitigaciónMitigationPandemiaPandemic

Identifiers

PMID36621243
PMCPMC9817760

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.